Airway gene-expression classifiers for respiratory syncytial virus (RSV) disease severity in infants

Lu Wang1, Chin-Yi Chu2, Matthew N McCall1

  • 1Department of Biostatistics and Computational Biology, University of Rochester School Medicine, Rochester, NY, USA.

BMC Medical Genomics
|February 26, 2021
PubMed

Insights

New biomarkers for respiratory syncytial virus (RSV) infection severity were identified using airway gene expression. These gene expression profiles can potentially predict severe illness in infants, aiding clinical decisions.

Area of Science:

  • Respiratory viral infections
  • Genomics and transcriptomics
  • Biomarker discovery

Background:

  • Respiratory syncytial virus (RSV) causes severe illness and hospitalization in many infants.
  • Current diagnostic methods lack accurate biomarkers for predicting RSV disease severity.
  • There is a critical need for reliable indicators of severe RSV infection in infants.

Purpose of the Study:

  • To identify airway gene expression profiles associated with respiratory syncytial virus (RSV) disease severity.
  • To develop potential biomarkers for predicting severe RSV infection in infants.
  • To correlate gene expression patterns with clinical illness severity scores.

Main Methods:

  • RNA sequencing was performed on nasal brush samples from 106 infants with RSV infection.
  • Gene expression profiles were analyzed during acute illness and convalescence.
  • Statistical models (NGSS1 and NGSS2) were developed to correlate gene expression with clinical severity scores (GRSS).

Main Results:

  • A 41-gene signature (NGSS1) strongly correlated with RSV disease severity (cross-validated correlation of 0.813).
  • NGSS1 achieved 89.6% accuracy in classifying mild versus severe RSV infection.
  • A 13-gene signature (NGSS2) showed comparable accuracy (84.0% classification accuracy).

Conclusions:

  • Airway gene expression patterns can serve as potential biomarkers for RSV disease severity.
  • Minimally-invasive sampling allows for the development of clinically useful biomarkers.
  • These findings may lead to improved prediction and management of severe RSV infections in infants.
Abstract

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.6K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
728
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
562
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.1K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
293
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
514